In contrast, continuous Foxp3 degradation for 4 weeks did not result in any noticeable clinical manifestations of autoimmune disease with only mildly increased state of immune cell activation observed (Fig. 1f–h and Extended Data Fig. 3a,b). The gene discussed is FOXP3; the disease is autoimmune disease.